线粒体
线粒体融合
细胞生物学
线粒体分裂
氧化应激
心肌保护
氧化磷酸化
活性氧
线粒体生物发生
生物
化学
线粒体DNA
医学
生物化学
缺血
内科学
基因
作者
Sauri Hernández‐Reséndiz,Mabel Buelna‐Chontal,Francisco Correa,Cecilia Zazueta
出处
期刊:Current Drug Targets
[Bentham Science]
日期:2013-04-01
卷期号:14 (5): 586-600
被引量:18
标识
DOI:10.2174/1389450111314050008
摘要
The critical role of mitochondria in cardiomyocyte survival and death has become an exciting field of research in cardiac biology. Indeed, it is accepted that mitochondrial dysfunction plays a crucial role in the pathogenesis of multiple cardiac diseases. Besides the obvious relevance of mitochondria in energy production, calcium homeostasis, and reactive oxygen species (ROS) production, new processes like mitochondrial fusion/fission, phosphorylation and nitrosylation modifications in mitochondrial proteins have been suggested to form part of a cast of key players in cardiac disease. This review describes currently studied drugs and compounds that target mitochondria in the scenario of cardiovascular diseases. Keywords: Apoptosis, cardioprotection, fusion and fission processes, mitochondrial biogenesis, mitochondrial calcium transport, oxidative stress.
科研通智能强力驱动
Strongly Powered by AbleSci AI